J1598 Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg

Billable / valid for submission HCPCS Release 2026Q3

Short description: Inj glycopyrrolate fres kabi

Version history

Release	Valid from	Valid to	Description	Billable
2026Q3	2026-07-01	current	Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg	yes

J1551 Injection, immune globulin (cutaquig), 100 mg
J1552 Injection, immune globulin (alyglo), 500 mg
J1553 Injection, immune globulin (yimmugo), 100 mg
J1554 Injection, immune globulin (asceniv), 500 mg
J1555 Injection, immune globulin (cuvitru), 100 mg
J1556 Injection, immune globulin (bivigam), 500 mg
J1557 Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg
J1558 Injection, immune globulin (xembify), 100 mg
J1559 Injection, immune globulin (hizentra), 100 mg
J1560 Injection, gamma globulin, intramuscular, over 10 cc
J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
J1566 Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
J1569 Injection, immune globulin, (gammagard liquid/gammagard liquid erc), 500 mg
J1570 Injection, ganciclovir sodium, 500 mg
J1571 Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml
J1572 Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg
J1573 Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
J1574 Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg
J1575 Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin